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Toxin B from Clostridium dificile was purified to homogeneity by gel filtration and high resolution ion exchange chroma- 
tography. Two forms of toxin B were found. Form 1 which seemed to consist of two identical subunits of 22&300 kDa; 
femtogram amounts of this toxin induced rounding of fibroblast cells. Form 2 contained subunits of 43 kDa and 105 
kDa; the stoichiometric ratio probably being 4: 1; picogram amounts were needed to induce rounding of fibroblast cells. 
Immunological studies suggested that both subunit types were antigenic and had epitopes which were identical with those 
of form 1. 
Cytotoxin; Diarrhea; Colitis; (Clostridium dzjicile) 
1. INTRODUCTION 
Clostridium difficile has been reported in 
association with cases of diarrhoea, colitis and 
pseudomembranous colitis in humans [1,2]. The 
bacterium produces two toxins, A and B, and these 
proteins probably mediate most of the pathogenic 
effects [3,4]. Toxin A is an enterotoxin causing in- 
testinal fluid secretion in animal models; toxin B is 
a cytotoxin causing cell damage in tissue cultures. 
Both toxins are lethal to mice after intraperitoneal 
injection of < 1 pg. 
Toxin B has proved to be difficult to purify to 
homogeneity, a property which has hindered its 
characterisation. Most reports agree that it is a 
large protein with a native M, from 400000 to 
600000 and subunits with an M, between 200000 
and 300000 [3,4]. However, a toxin with subunits 
of smaller size (50 kDa) has also been reported 
[5,6], but the purity of these preparations has been 
questioned (71. In this report, we provide chemical 
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and immunological evidence that both forms of 
toxin B exist and are produced by the same 
bacterial strain. 
2. MATERIALS AND METHODS 
2.1. Culture conditions 
C. difficciie CCUG 19126 (VP1 10463, obtained from DM 
Lyerly/TD Wilkins, VP1 Blacksburg, USA) was used for toxin 
production. The organism was grown in 2-l brain heart infusion 
dialysis flasks, as described [8]. Culture was incubated at 37°C 
for 96 h, and a cell-free supernatant was obtained by cen- 
trifugation and filtration. 
2.2. Purification of toxin B 
An overview of the various procedures used for the purifica- 
tion of toxin B is shown in table 1. The culture filtrate was con- 
centrated in an ultrafiltration cell with an XMlOOA membrane 
(Amicon, USA), and toxin B was separated from toxin A in 
DEAE-Sephadex A25 as outlined [3]. Fractions with toxin B 
activity were concentrated to 5-6 ml, by ultrafiltration using an 
XM50 membrane (Amicon), and applied onto a 2.6 x 76 cm 
column of Sephacryl S400 (Pharmacia, Sweden). Elution was 
done with 0.05 M triethanolamine, pH 7.5, containing 0.2 M 
NaCl. Fractions with cytotoxic activity were concentrated and 
equilibrated in triethanolamine 0.2 M, pH 7.5 (buffer l), by 
washing 3 times with the buffer on an ultrafiltration XM50 
membrane. The sample was then applied onto a 5 mm x 5 cm 
Mono QHR 5/5 column (Pharmacia), coupled to a fast protein 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 0 1988 Federation of European Biochemical Societies 417 
Volume 233, number 2 FEBS LETTERS June 1988 
Table 1 
Purification step 
Purification of form 1 of toxin B produced by C. difficik 
Protein Cytotoxicitya 
vol., ml mg/ml Total mg Total CU CU/pg 
Cell-free culture 300 3.93 1180 9.5 x 10’2 8 
DEAE-Sephadex A25 10 7.90 55 6.1 x 10” 120 
Sephacryl S-400 25 0.37 9.2 5.8 x IO’* 620 
Mono Q, FPLCb 5.0 0.22 1.1 4.6 x lOI2 4200 
a Expressed as cytotoxic units (0) i.e. the inverse of the maximal dilution which induced rounding of human lung fibroblast cells 
b Fast protein liquid chromatography on a Mono Q column as shown in fig.1 
liquid chromatography (FPLC) system (Pharmacia), the flow 
rate being 0.75 ml/min and the fraction volume 1 ml. After an 
initial washing with 0.44 M NaCl in buffer 1, the toxin was 
eluted in a gradient of 0.44 to 0.52 NaCl in buffer 1 (fig.1). 
Samples with toxin B activity were concentrated to about 
1 mg/ml of protein, and kept at 4°C for further analysis. 
b 
Fig.]. Fast protein liquid chromatography of toxin B on a 
Mono Q column. (a) NaCl gradient used for elution. (b) Elution 
of toxin B form 1. (c) Elution of toxin B, form 2. -, ab- 
sorbance at 280 nm; - - - -, cytotoxic activity. 
2.3. Toxicity assay 
Human lung fibroblast cells were used to measure the activity 
of toxin B, as described [9]. Cytotoxic units are expressed as the 
inverse of the maximal dilution which induced rounding in at 
least 50% of the cells. 
2.4. Polyacrylamide gel electrophoresis (PAGE) 
Samples were analysed in precast polyacrylamide gradient 
gels (Pharmacia). Non-denaturing PAGE was run in a 4-30% 
gradient at pH 8.4, in accordance with the manufacturer’s in- 
structions. Some unstained gels were sliced into sections, and 
the active toxin eluted by dialysis against phosphate buffered 
saline, containing 0.15 M NaCI, 0.1% sodium thiosulphate, 
and 0.01 M sodium phosphate, pH 7.2. Denaturing PAGE in 
the presence of SDS was run at pH 7.4, and a 2-16% gradient 
gel (as recommended by Pharmacia). The gels were stained with 
0.1 Vo Coomassie blue R-250. Some gels were scanned in a dual- 
wavelength densitometer (Shimadzu CS-910) to determine the 
proportion of each stained spot. 
2.5. Immunological methods 
New Zealand rabbits were used to prepare antisera against 
toxin B. Animals were initially inoculated with 20 pg of protein 
in complete Freund’s adjuvant by multiple intradermal dorsal 
injection. 10 days later, they were inoculated with 20 pg of pro- 
tein in incomplete Freund’s adjuvant, again by multiple intra- 
dermal dorsal injection. This procedure was repeated 8 times. 
Eight days after the last injection, animals were bled to death 
and the serum prepared. 
The antigen-antibody reaction was analysed by double 
diffusion-in-gel [lo]. lo-20 pg of antigen was used in each well, 
and the antiserum was undiluted. After 48 h of diffusion, the 
microplate was washed with 0.15 M NaCl and stained with 
Coomassie blue R-250. 
3. RESULTS 
The crude culture filtrate contained between 5 
and 10 x 1Ol2 cytotoxic units per ml (CU/ml) of 
toxin B. The toxin was purified to homogeneity by 
chromatography successively on DEAE-Sephadex, 
Sephacryl S-400 and Mono Q (table 1). The 
DEAE-Sephadex step separated toxin B from toxin 
A, giving a 15fold increase in specific activity of 
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Fig.2. Polyacrylamide gel electrophoresis of toxin B. (a) Elec- 
trophoresis under non-denaturing conditions; rows 1 and 2, 
toxin B form 2, before and after FPLC, respectively; row 3, 
molecular mass markers; rows 4 and 5, toxin B form 1 before 
and after FPLC, respectively. Arrows on both sides indicate the 
zone from which activity was recovered. (b) Electrophoresis in 
the presence of SDS; rows 1 and 2, toxin B form 2 without and 
with ,&mercaptoethanol, respectively; rows 3 and 4, toxin B 
form 1 without and with ,8-mercaptoethanol, respectively; row 
5, molecular mass markers. 
toxin B. The subsequent filtration through 
Sephacryl S-400 increased the specific activity 
about five times with a yield of 80-90%. 
The final purification step was high perfor- 
mance liquid chromatography (FPLC) on Mono 
Q, using a combination of discontinuous and con- 
tinuous NaCl gradients (fig.1). Most of the con- 
taminating proteins eluted before toxin B which 
eluted at 0.48-0.49 M NaCl. The specific activity 
increased about 7 times in this step, and the yield 
was about 80%. In all, the 3 steps gave 
500-600-fold purification, and a yield of about 
50%. Some lots of toxin B (form 2) behaved dif- 
ferently on FPLC, the toxin eluting at 0.46-0.47 M 
NaCl (fig.lc). The yields and specific activity 
before FPLC were similar for the two forms, but 
after FPLC form 2 had less activity than form 1. 
Both forms of toxin were analysed with gradient 
PAGE (fig.2). Under non-denaturing conditions, 
form 1 appeared at a position representing 
450-500 kDa (row 5), but form 2 at 300-400 kDa 
(row 2). Further, the toxic activity was entirely 
recovered from these regions (fig.2a, arrows), 
when the unstained gel was sliced into small pieces 
and eluted with buffer. In SDS-PAGE, the two 
toxins differed substantially in their subunit com- 
position (fig.2b). Form 1 migrated in SDS as one 
band of 220-300 kDa, both in non-reduced (row 3) 
and reduced conditions (row 4). In contrast, the 
non-reduced form 2 migrated in two bands of 
molecular masses of 105 and 45 kDa, containing 
34 and 63% of stained material, respectively (row 
1). In reducing conditions, form 2 migrated as one 
component of 43 kDa (row 2). These results sug- 
gest that form 1 is composed of two subunits of 
about 250 kDa; form 2 is probably composed of 
four smaller subunits and one larger subunit, the 
larger being an S-S bridged dim& of two peptides, 
similar in mass to the smaller subunit. In one 
Fig.3. Analysis in double immunodiffusion-in-gel of toxin B. 
(a) Pos.1, antiserum against toxin B form 1; pos.2, antiserum 
against toxin B form 2; pos.3 and 4, toxin B form 1, before and 
after FPLC, respectively; pos.5, toxin A. (b) Pos.1, antiserum 
against toxin B form 1; pos.2, antiserum against toxin B form 
2; pos.3, toxin B form 1; pos.4 and 5, toxin B form 2. 
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preparation of the toxin, two bands were obtained 
in gradient PAGE at positions corresponding to 
form 1 and form 2 (not shown); SDS-PAGE in the 
presence of mercaptoethanol revealed the existence 
of subunits of molecular masses of 230 and 43 kDa 
(i.e. the subunits of form 1 and form 2). 
Two different antisera against toxin B were 
prepared, one against form 1 and the other against 
form 2. The former antiserum had a high 
neutralisation capacity; 1 ml neutralised 10’ CU of 
toxin B form 1, whereas the antiserum against 
form 2 neutralised only lo2 CU/ml. Neither of the 
antisera showed any inhibition of toxin A. The 
antigen-antibody reaction was further analysed by 
immunodiffusion. As shown in fig.‘3a, the pure 
form 1 precipitated in one line both with antisera 
against form 1 and against form 2; the antiserum 
against toxin B did not recognise toxin A. As 
shown in fig.3b, toxin B, form 2, precipitated in 
two lines with its own antiserum, both lines fusing 
with that of form 1. This suggests that form 2 is 
composed of two antigenically different types of 
subunits, both of which have antigenic deter- 
minants in common with form 1. 
4. DISCUSSION 
Using the 10463 strain of C. difficife Lyerly et al. 
[l l] and Pothoulakis et al. [6] obtained prepara- 
tions of toxin B which differed in their chemical 
properties. Thus, the former group reported that 
the toxin consisted of subunits of M, 300 000 while 
the latter determined the subunit size at 50000. 
Our results suggest hat two forms of toxin B are 
produced by the 10463 strain: form 1 is probably 
identical with that described by Lyerly et al. and 
form 2 is probably identical with that described by 
Pothoulakis et al. 
Comparison of the two forms in immunodiffu- 
sion revealed that the antigenic determinants of the 
two forms were similar, if not identical. Form 2, 
however, in contrast to form 1, contained two 
precipitogens which probably corresponded to the 
105 kDa and 50 kDa subunits seen in SDS-PAGE. 
Interestingly, a similar toxin was recently isolated 
from C. sordeiii broth [ 121. This toxin cross- 
reacted antigenically with toxin B and was com- 
posed of about five subunits each of a molecular 
mass of 50 kDa. 
The existence of different forms of one toxin has 
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also been reported in a species of Bacillus. In B. 
sphaericus, for instance, toxic peptides varying 
from 110 to 39 kDa have been purified [13], and 
proteases have been suggested to hydrolyse the in- 
tact toxin into smaller polypeptides. Again, in B. 
thuringiensis two similar 130 kDa mosquitocidal 
toxins are probably encoded by two independent 
genes [14]. Further studies are needed to clarify 
whether the forms of toxin B reported here are en- 
coded by different genes, or the result of the action 
of hydrolysing enzymes. 
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